ST. LOUIS, Mo. (KMOX) – Researchers at Saint Louis University say they’re making progress towards a genital herpes vaccine.
At the end of the large scale study involving more than 8,000 women, many in the St. Louis area co-investigator Dr. Sharon Frey with the Center for Vaccine Development at Saint Louis University says the vaccine didn’t accomplished exactly what they had hoped it would do. But “this is still an exciting finding unfortunately the vaccine did not protect against herpes simplex virus type 2 (HSV-2),” explains Frey.
Researchers hoped to create a vaccine that would protect against all types of herpes genital infections only protected against herpes simplex virus type 1 (HSV-1), which mainly causes sores in the mouth and lips.
However Dr. Frey said the team made an unexpected discovery, “we are learning that more and more genital herpes is being caused by simplex 1 herpes.”
Dr. Frey says her team will continue their work on creating a vaccine to protect against all types of herpes.
Copyright KMOX Radio